Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WisdoMont Asset Management is a China-based venture capital and private equity investment firm focused on healthcare and, to a lesser extent, AI/big data opportunities. Founded in 2014, the firm invests across the global healthcare industry from early-stage companies to larger multinational businesses. It appears to operate primarily as an asset manager and investor rather than a therapeutic product developer, with activity in biopharma, medical technology, healthcare services, and related sectors. Public references connect the firm with investments in companies such as AceLink Therapeutics, X-Imaging, Hanhong Technology, and healthcare-related financing transactions involving Concord Medical. Based on the available evidence, WisdoMont should be characterized as a healthcare-focused investment platform rather than a biotech or pharma operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WisdoMont.